RecruitingNot applicableNCT05164107

Safety and Performance of a Pulsed Field Device for Global Mapping and Ablation of the Left Atrium for the Treatment of Atrial Fibrillation

Studying Familial LCAT deficiency

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Kardium Inc.
Principal Investigator
Motol and Homolka University Hospital
V Úvalu 84/1, 150 00 Prague 5, Czech Republic
Intervention
Globe Mapping and Pulsed Field Ablation System (Globe PF System)(device)
Enrollment
175 target
Eligibility
18-75 years · All sexes
Timeline
20212027

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT05164107 on ClinicalTrials.gov

Other trials for Familial LCAT deficiency

Additional recruiting or active studies for the same condition.

See all trials for Familial LCAT deficiency

← Back to all trials